Equities

Arcticzymes Technologies ASA

Arcticzymes Technologies ASA

Actions
  • Price (NOK)25.20
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change-31.52%
  • Beta--
Data delayed at least 15 minutes, as of May 07 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.

  • Revenue in NOK (TTM)118.94m
  • Net income in NOK18.72m
  • Incorporated1995
  • Employees61.00
  • Location
    Arcticzymes Technologies ASASykehusveien 23TROMSO 9019NorwayNOR
  • Phone+47 77648900
  • Fax+47 77648901
  • Websitehttps://arcticzymes.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.